181 related articles for article (PubMed ID: 6460704)
1. Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2.
Vose BM; Bonnard GD
Int J Cancer; 1982 Jan; 29(1):33-9. PubMed ID: 6460704
[TBL] [Abstract][Full Text] [Related]
2. Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays.
Vose BM; White W
Cancer Immunol Immunother; 1983; 15(3):227-36. PubMed ID: 6225511
[TBL] [Abstract][Full Text] [Related]
3. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
Uchida A; Moore M
Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
[TBL] [Abstract][Full Text] [Related]
4. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
5. Expansion of autorecognitive cytotoxic effectors in human cancer by T cell growth factor (Interleukin 2)1.
Vose BM
Arch Geschwulstforsch; 1981; 51(4):317-26. PubMed ID: 6459065
[TBL] [Abstract][Full Text] [Related]
6. In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma.
Apiranthitou-Drogari M; Paganin C; Bernasconi S; Losa G; Maneo A; Colombo N; Mantovani A; Allavena P
Cancer Immunol Immunother; 1992; 35(4):289-95. PubMed ID: 1387344
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site.
Vose BM
Int J Cancer; 1982 Aug; 30(2):135-42. PubMed ID: 6215363
[TBL] [Abstract][Full Text] [Related]
8. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
9. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cells.
Roth AD; Dupuis S; Alberto P
Clin Exp Immunol; 1995 Aug; 101(2):362-8. PubMed ID: 7648722
[TBL] [Abstract][Full Text] [Related]
11. Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
Vánky F; Gorsky T; Gorsky Y; Masucci MG; Klein E
J Exp Med; 1982 Jan; 155(1):83-95. PubMed ID: 6459402
[TBL] [Abstract][Full Text] [Related]
12. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
Uchida A; Moore M; Klein E
Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
[TBL] [Abstract][Full Text] [Related]
13. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
14. [Cytotoxicity of lymphocytes sensitized by autologous tumor cells in vitro, against autologous lung cancer cell lines].
Inaba H; Kobayashi S; Okada S; Fujimura S; Nakata T
Nihon Geka Gakkai Zasshi; 1990 Apr; 91(4):515-23. PubMed ID: 2142996
[TBL] [Abstract][Full Text] [Related]
15. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
16. Generation of human cytotoxic T lymphocytes against fresh autologous and allogeneic solid tumors by mixed lymphocyte tumor cell culture with T cell growth factor.
Ichino Y; Ishikawa T
Gan; 1984 May; 75(5):436-41. PubMed ID: 6235143
[TBL] [Abstract][Full Text] [Related]
17. Electron microscopic observation of killer cells induced by mixed culture of lymphocytes with autologous cancer cells and further culture with recombinant interleukin-2.
Murakami H; Matsuoka H; Fukiage T; Samejima Y; Eura M; Ikawa T; Ishikawa T; Kanda T
Auris Nasus Larynx; 1992; 19(3):175-88. PubMed ID: 1489283
[TBL] [Abstract][Full Text] [Related]
18. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic studies in human newborns: lessened allogeneic cell-induced (augmented) cytotoxicity but strong lymphokine-activated cytotoxicity of cord mononuclear cells.
Chin TW; Ank BJ; Murakami D; Gill M; Spina C; Strom S; Stiehm ER
Cell Immunol; 1986 Dec; 103(2):241-51. PubMed ID: 2433051
[TBL] [Abstract][Full Text] [Related]
20. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
